JENNA BLETZACKER: Open Payments
NPI 1801293808 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 19 payments from 6 companies in 2025. Trend: 2023 $246 · 2024 $176 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $248 |
| Boston Scientific Corporation | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $24 |
| Organon LLC | 1 | $18 |
| MILLICENT US INC | 1 | $16 |
Products named: GEMTESA, Bulkamid - Bulkamid Urethral Bulking Pack 2mL (OUS), Kyleena, Veozah, NEXPLANON, INTRAROSA, MYFEMBREE.
Industry payments across TN — which companies pay providers there.
